Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer.

MLA

Schultz, Christopher W., et al. “Author Correction: ATR Inhibition Augments the Efficacy of Lurbinectedin in Small-Cell Lung Cancer.” EMBO Molecular Medicine, vol. 16, no. 3, Mar. 2024, p. 664. EBSCOhost, https://doi.org/10.1038/s44321-024-00029-x.

APA

Schultz, C. W., Zhang, Y., Elmeskini, R., Zimmermann, A., Fu, H., Murai, Y., Wangsa, D., Kumar, S., Takahashi, N., Atkinson, D., Saha, L. K., Lee, C.-F., Elenbaas, B., Desai, P., Sebastian, R., Sharma, A. K., Abel, M., Schroeder, B., Krishnamurthy, M., … Thomas, A. (2024). Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer. EMBO Molecular Medicine, 16(3), 664. https://doi.org/10.1038/s44321-024-00029-x

Chicago

Schultz, Christopher W, Yang Zhang, Rajaa Elmeskini, Astrid Zimmermann, Haiqing Fu, Yasuhisa Murai, Darawalee Wangsa, et al. 2024. “Author Correction: ATR Inhibition Augments the Efficacy of Lurbinectedin in Small-Cell Lung Cancer.” EMBO Molecular Medicine 16 (3): 664. doi:10.1038/s44321-024-00029-x.